IP Library › Granted Patent US 9,416,405
Granted Patent B2
US 9,416,405 · App. 14/071,444 · Granted Aug 16, 2016

Compositions, methods and kits for enhancing PCR specificity

Inventors: Shoulian Dong (Mountain View, CA); Chunmei Liu (Palo Alto, CA)
Assignee: Life Technologies Corporation
C12Q1/6855C12P19/34C12Q1/686C12Q1/6851C12Q1/6858C12Q1/6832C12Q1/6848
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,416,405
App. No.
14/071,444
Granted
Aug 16, 2016
Kind
B2
Abstract

The present disclosure provides novel primers and method for the detection of specific nucleic acid sequences. The primers and methods provided herein are useful in a wide variety of molecular biology applications and are particularly useful in allele-specific PCR.

Claims (32)

1. A composition comprising

a first oligonucleotide primer comprising a 5′ Sequence-Targeted Amplification Restrictive (STAR) tag sequence portion and a target nucleic acid hybridization sequence portion; and

a second oligonucleotide primer comprising a target nucleic acid hybridization sequence portion, wherein the STAR tag sequence is the same as all or a portion of the target nucleic acid hybridization sequence of the second oligonucleotide primer and the STAR tag sequence is the same as a sequence in the target nucleic acid 5′ of the first oligonucleotide target nucleic acid hybridization sequence hybridization site.

2. The composition of claim 1 , wherein the sequence shared between the first and the second primers is between about 3 and about 15 nucleotides in length.

3. The composition of claim 1 , wherein the first oligonucleotide primer and the second oligonucleotide primer are a pair of forward and reverse amplification primers.

4. The composition of claim 1 further comprising a polynucleotide extension product comprising the STAR tag sequence at the 5′ end and a sequence complementary to the STAR tag sequence to the 3′ side of the STAR tag sequence, wherein the STAR tag sequence and the complementary sequence render the extension product capable of forming a stem-loop structure.

5. A method of detecting a nucleic acid comprising:

contacting the target nucleic acid with a composition of claim 1 ;

hybridizing the target nucleic acid with the first oligonucleotide primer;

extending the oligonucleotide to form an extension product;

amplifying the extension product to form an amplification product; and

detecting the presence or absence of the amplification product, thereby detecting the target nucleic acid.

6. A method of inhibiting or substantially blocking undesired amplification of a target nucleic acid comprising:

contacting the target nucleic acid with a composition of claim 1 ;

hybridizing the target nucleic acid with the first oligonucleotide primer;

extending the oligonucleotide to form an extension product;

incubating the extension product with an amplification reaction mixture; and

detecting the presence or absence of the extension product.

7. A method of inhibiting or substantially blocking undesired amplification of a target nucleic acid comprising:

contacting the target nucleic acid with a composition of claim 1 ;

hybridizing the target nucleic acid with the first oligonucleotide primer; and

extending the oligonucleotide to form an extension product, wherein the extension product inhibits or substantially reduces undesired amplification of the target nucleic acid.

8. The composition of claim 1 , wherein the STAR tag sequence further comprises a sequence the same as a portion of an internal amplicon sequence of the target nucleic acid.

9. The composition of claim 1 , wherein the STAR tag sequence is about 10 to about 40 nucleotides in length.

10. The composition of claim 2 , wherein the sequence shared between the first and the second primers is 11, 12, or 13 nucleotides in length.

11. A composition comprising

a first oligonucleotide primer comprising a 5′ Sequence-Targeted Amplification Restrictive (STAR) tag sequence portion and a target nucleic acid hybridization sequence portion; and

a second oligonucleotide primer comprising a target nucleic acid hybridization sequence portion, wherein the STAR tag sequence is complementary to all or a portion of the target nucleic acid hybridization sequence of the second oligonucleotide primer and the STAR tag sequence is the same as a sequence in the target nucleic acid 5′ of the first oligonucleotide target nucleic acid hybridization sequence hybridization site.

12. The composition of claim 11 , wherein the STAR tag sequence further comprises a sequence the same as an internal amplicon sequence of the target nucleic acid.

13. The composition of claim 11 , wherein the STAR tag sequence is about 10 to about 40 nucleotides in length.

14. The composition of claim 11 , wherein the complementary sequence between the first and the second primers is between about 3 and about 15 nucleotides in length.

15. The composition of claim 11 further comprising a polynucleotide extension product comprising the STAR tag sequence at the 5′ end and a sequence complementary to the STAR tag sequence to the 3′ side of the STAR tag sequence, wherein the STAR tag sequence and the complementary sequence render the extension product capable of forming a stem-loop structure.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 13, 2014
From: DONG, SHOULIAN; LIU, CHUNMEI
To: LIFE TECHNOLOGIES CORPORATION
Reel/Frame 031948/0812 →
Continuity (3)
Provisional Application 61740242 · Dec 20, 2012
Provisional Application 61721968 · Nov 2, 2012
Related Publication 20140134614A1 · May 15, 2014